Zobrazeno 1 - 10
of 90
pro vyhledávání: '"John J Atherton"'
Autor:
Christopher M Reid, Jamie Rankin, Suzanne Robinson, Amit Shah, Andrew Maiorana, John J Atherton, Tashi Dorje, Graham Hillis, Angela Jacques, Liying Dai, Jan Gootjes, Lawrence Dembo
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction General practitioners (GPs) routinely provide care for patients with heart failure (HF); however, adherence to management guidelines, including titrating medication to optimal dose, can be challenging in this setting. This study will eva
Externí odkaz:
https://doaj.org/article/ec98a22074bb464fa6f43e6c48ba693f
Autor:
Leticia Bezerra Giordan, Huong Ly Tong, John J Atherton, Rimante Ronto, Josephine Chau, David Kaye, Tim Shaw, Clara Chow, Liliana Laranjo
Publikováno v:
JMIR Cardio, Vol 6, Iss 1, p e33839 (2022)
BackgroundHeart failure self-management is essential to avoid decompensation and readmissions. Mobile apps seem promising in supporting heart failure self-management, and there has been a rapid growth in publications in this area. However, to date, s
Externí odkaz:
https://doaj.org/article/baa47a98f04d42c19150d6abf740627b
Autor:
Michael Gramlich, Luna Simona Pane, Qifeng Zhou, Zhifen Chen, Marta Murgia, Sonja Schötterl, Alexander Goedel, Katja Metzger, Thomas Brade, Elvira Parrotta, Martin Schaller, Brenda Gerull, Ludwig Thierfelder, Annemieke Aartsma‐Rus, Siegfried Labeit, John J Atherton, Julie McGaughran, Richard P Harvey, Daniel Sinnecker, Matthias Mann, Karl‐Ludwig Laugwitz, Meinrad Paul Gawaz, Alessandra Moretti
Publikováno v:
EMBO Molecular Medicine, Vol 7, Iss 5, Pp 562-576 (2015)
Abstract Frameshift mutations in the TTN gene encoding titin are a major cause for inherited forms of dilated cardiomyopathy (DCM), a heart disease characterized by ventricular dilatation, systolic dysfunction, and progressive heart failure. To date,
Externí odkaz:
https://doaj.org/article/7c654a80f21048ac9a078d405a3d0a79
Autor:
Xi Zhang, Daniel Broszczak, Karam Kostner, Kristyan B Guppy-Coles, John J Atherton, Chamindie Punyadeera
Publikováno v:
Biomolecules, Vol 9, Iss 12, p 766 (2019)
Screening for systolic heart failure (SHF) has been problematic. Heart failure management guidelines suggest screening for structural heart disease and SHF prevention strategies should be a top priority. We developed a multi-protein biomarker panel u
Externí odkaz:
https://doaj.org/article/4f2dfc29acf74e9695b2dae9d30b46ce
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153479 (2016)
INTRODUCTION:Right ventricular (RV) systolic dysfunction is now recognized widely as a strong and independent predictor of adverse outcomes in patients with heart failure (HF). Reduction of RV systolic function more closely predicts impaired exercise
Externí odkaz:
https://doaj.org/article/25ebf9fb385c4ebaa74f4eb16b23b40f
Publikováno v:
Collegian. 29:894-903
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b0400a5a3127858e4f06b24f1339471
https://doi.org/10.1016/j.colegn.2022.05.012
https://doi.org/10.1016/j.colegn.2022.05.012
Autor:
Anish Krishnan, Sandhir B. Prasad, Kristyan B. Guppy-Coles, David J. Holland, Christopher Hammett, Gillian Whalley, Liza Thomas, John J. Atherton
Publikováno v:
Heart, Lung and Circulation. 31:795-803
Whilst the left ventricular ejection fraction (LVEF) remains the primary echocardiographic measure widely utilised for risk stratification following myocardial infarction (MI), it has a number of well recognised limitations. The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6f0f5fd7e82b02907abb49eaf54660
https://doi.org/10.1016/j.hlc.2022.01.005
https://doi.org/10.1016/j.hlc.2022.01.005
Autor:
Liying Dai, Tashi Dorje, Jan Gootjes, Amit Shah, Lawrence Dembo, Jamie Rankin, Graham Hillis, Suzanne Robinson, John J Atherton, Angela Jacques, Christopher M Reid, Andrew Maiorana
Publikováno v:
BMJ Open. 13:e063656
IntroductionGeneral practitioners (GPs) routinely provide care for patients with heart failure (HF); however, adherence to management guidelines, including titrating medication to optimal dose, can be challenging in this setting. This study will eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3486e6e7d479bf1ac934d8de6ef32cb
https://doi.org/10.1136/bmjopen-2022-063656
https://doi.org/10.1136/bmjopen-2022-063656
Autor:
Andrew P Sindone, Carmine De Pasquale, John Amerena, Christine Burdeniuk, Alicia Chan, Andrew Coats, David L Hare, Peter Macdonald, Aaron Sverdlov, John J Atherton
Publikováno v:
The Medical journal of Australia. 217(4)
This consensus statement of Australian clinicians provides new recommendations for the pharmacological management of heart failure based on studies reported since the publication of the 2018 Australian heart failure guidelines.▪Use of sodium-glucos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::579e78da23c641220b49d830a15d0d89
https://pubmed.ncbi.nlm.nih.gov/35908234
https://pubmed.ncbi.nlm.nih.gov/35908234
Autor:
Nicole K. Bart, Liza Thomas, Dariusz Korczyk, John J. Atherton, Graeme J. Stewart, Diane Fatkin
Publikováno v:
Heart, Lung and Circulation. 29:575-583
Amyloid cardiomyopathy is emerging as an important and under-recognised cause of heart failure and cardiac arrhythmias, especially in older adults. This disorder is characterised by extracellular deposition of amyloid fibrils that form due to misfold
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac3a2512e43ccf158cca05f295a26e2
https://doi.org/10.1016/j.hlc.2019.11.019
https://doi.org/10.1016/j.hlc.2019.11.019